Collision Tumor in Brooke-Spiegler Syndrome: a Case Report
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Malignant Cylindroma in a Patient with Brooke-Spiegler Syndrome
DERMATOLOGY PRACTICAL & CONCEPTUAL www.derm101.com Malignant cylindroma in a patient with Brooke-Spiegler syndrome Liliane Borik1,2, Patricia Heller2, Monica Shrivastava3, Viktoryia Kazlouskaya2 1 Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology, Medical University of Vienna, Vienna, Austria 2 Ackerman Academy of Dermatopathology, New York, NY, USA 3 Advanced Laser Skin Center, Teaneck, NJ, USA Key words: adnexal neoplasm, apocrine neoplasm, cylindroma, cylindrocarcinoma Citation: Borik L, Heller P, Shrivastava M, Kazlouskaya V. Malignant cylindroma in a patient with Brooke-Spiegler syndrome. Dermatol Pract Concept 2015;5(2):9. doi: 10.5826/dpc.0502a09 Received: October 17, 2014; Accepted: January 9, 2015; Published: April 30, 2015 Copyright: ©2015 Kazlouskaya et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Funding: None. Competing interests: The authors have no conflicts of interest to disclose. All authors have contributed significantly to this publication. Corresponding author: Viktoryia Kazlouskaya, MD, PhD, Ackerman Academy of Dermatopathology ,145 E 32 St, 10th Fl, New York, NY 10036, USA. Tel. 347-488-8058. E-mail: [email protected] ABSTRACT Malignant cylindroma (cylindromatous carcinoma, cylindrocarcinoma) is the malignant counterpart of benign cylindroma. It is a rare neoplasm, more often developing in the setting of multiple pre- existing benign neoplasms. Herein we present an additional case of malignant transformation of the cylindroma diagnosed in an 83-year-old patient with known Brooke-Spiegler syndrome. Case presentation Figure 1. Multiple nodules An 83-year-old patient presented to the dermatologist in the central numerous times with multiple lesions on the face, scalp and face. -
Rotana Alsaggaf, MS
Neoplasms and Factors Associated with Their Development in Patients Diagnosed with Myotonic Dystrophy Type I Item Type dissertation Authors Alsaggaf, Rotana Publication Date 2018 Abstract Background. Recent epidemiological studies have provided evidence that myotonic dystrophy type I (DM1) patients are at excess risk of cancer, but inconsistencies in reported cancer sites exist. The risk of benign tumors and contributing factors to tu... Keywords Cancer; Tumors; Cataract; Comorbidity; Diabetes Mellitus; Myotonic Dystrophy; Neoplasms; Thyroid Diseases Download date 07/10/2021 07:06:48 Link to Item http://hdl.handle.net/10713/7926 Rotana Alsaggaf, M.S. Pre-doctoral Fellow - Clinical Genetics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, NIH PhD Candidate – Department of Epidemiology & Public Health, University of Maryland, Baltimore Contact Information Business Address 9609 Medical Center Drive, 6E530 Rockville, MD 20850 Business Phone 240-276-6402 Emails [email protected] [email protected] Education University of Maryland – Baltimore, Baltimore, MD Ongoing Ph.D. Epidemiology Expected graduation: May 2018 2015 M.S. Epidemiology & Preventive Medicine Concentration: Human Genetics 2014 GradCert. Research Ethics Colorado State University, Fort Collins, CO 2009 B.S. Biological Science Minor: Biomedical Sciences 2009 Cert. Biomedical Engineering Interdisciplinary studies program Professional Experience Research Experience 2016 – present Pre-doctoral Fellow National Cancer Institute, National Institutes -
Dermal Cylindroma of the Scalp (Turban Tumour) and Subjacent Calvarian Defects
ANTICANCER RESEARCH 30: 1793-1798 (2010) Dermal Cylindroma of the Scalp (Turban Tumour) and Subjacent Calvarian Defects REINHARD E. FRIEDRICH Department of Oral and Maxillofacial Surgery, Eppendorf University Hospital, University of Hamburg, Germany Abstract. This case report describes the diagnosis and Case Report therapy of a patient with a 40-year history of multiple potato-like tumours growing in the head and neck region. Patient. A seventy-five-year-old woman was referred to the The tumour proved to be a cylindroma, associated with Department of Oral and Maxillofacial Surgery from the calvarian defects. Further facial tumours were diagnosed as Department of Dermatology, Eppendorf University Hospital, trichoepitheliomas. This association of findings was for treatment of an extensive cylindroma of the entire scalp. pathognomonic for Brooke-Spiegler’s syndrome. Complete The patient first sought for medical advice in the University work-up of the resection specimen excluded any malignant Hospital 4 years previously but had refused any surgical transformation of the tumour. A long lasting history of treatment (Figure 1). On presentation, the patient was in cylindroma and evidence for bone destruction, not associated generally good condition. The primary reason the patient with a malignant transformation, is extremely rare in decided to seek surgical treatment was an ill-fit of her wig Brooke-Spiegler’s syndrome. (Figure 2). The patient’s medical history showed an early onset of the enlargement of the skin of her skull and the development Cylindroma is a slow growing, benign tumour of the skin (1), of potato-like tumours about 40 years earlier. At the same time, affecting preferentially the head and neck region, especially she noticed a growing baldness in the area of tumour growth the capillitium and forehead (2, 3). -
FNA of Tumors of Unknown Primary in the Head and Neck Jeffrey F
FNA of Basaloid Neoplasms of the Head and Neck Jeffrey F. Krane, MD PhD Professor of Pathology David Geffen School of Medicine at UCLA Overview • Case based approach • Basaloid tumors and closely related entities • Review – Common clinical presentations – Cytologic features – Adjunctive techniques as appropriate Basaloid Tumors • Sparse cytoplasm confers an immature appearance • Need to rely on other clues to classify – Chromatin – Matrix – Architecture/Smear pattern – Non-basaloid areas Two Main Scenarios • Basaloid salivary gland tumors • Basaloid metastases in neck lymph nodes Salivary Gland Tumors Salivary gland neoplasms Clinical Management • Superficial parotid gland is most common site • Benign tumor/Low-grade carcinoma Excision of the mass (partial parotidectomy) • High-grade carcinoma Radical surgery (complete parotidectomy) Neck dissection? Radiation therapy Challenging Salivary Gland Patterns Benign/LG Malignant HG Malignant • Oncocytic/Clear cell • High-grade • Spindle cell • Cystic/Mucinous Basaloid neoplasms Basaloid pattern is most problematic Differential diagnosis spans benign, low-grade and high-grade carcinomas Case 1: History • A 79 year-old woman with a 5 month history of a firm, mobile 2 cm non-tender parotid mass. Case 1 Case 1 Case 1 Case 1 Case 1 Case 1 Case 1: Diagnosis? A. Adenoid cystic carcinoma B. Basal cell adenoma C. Skin adnexal neoplasm D. Basaloid squamous cell carcinoma Case 1 Case 1: Diagnosis? Basal cell adenoma, membranous type Basaloid neoplasms: Differential Diagnosis • Benign: Basal cell adenoma, -
Salivary Gland Pathology Salivary Gland Pathology 2007 June Cheng-Chung Lin Prof
Salivary Gland Pathology Salivary Gland Pathology 2007 June Cheng-Chung Lin Prof. in Oral Pathology Kaohsiung Med University E-mail: [email protected] Histological Classification of Salivary Gland Tumors (WHO) 1. Adenomas 2.13. Malignant myoepithelioma 1.2. Pleomorphic Adenoma 2.14. Carcinoma in PA 1.3. Basal cell adenoma (Malignant mixed tumor) 1.4. Warthin tumor 2.15. Squamous cell carcinoma 1.5. Oncocytoma(Oncocytic adenoma) 2.16. Small cell carcinoma 1.6. Canalicular adenoma 2.17. Undifferentiated carcinoma 1.7. Sebaceous adenoma 2.18. Other carcinomas 1.8. Ductal papilloma 3. Non-epithelial tumors 1.8.1 Inverted ductal papilloma 4. Malignant Lymphomas 1.8.2. Intraductal papilloma 5. Secondary tumors 1.8.3. Sialadenoma papilliferum 6. Unclassified tumors 1.9. Cystadenoma 7. Tumor-like lesions 1.9.1. Papillary cystadenoma 7.1. Sialadenosis 1.9.2. Mucinous cystadenoma 7.2. Oncocytosis 2. Carcinomas 7.3. Necrotizing sialometaplasia 7.4. Benign lymphoepithelial lesion 2.2. Mucoepidermoid carcinoma 7.5. Salivary gland cysts 2.3. Adenoid cystic carcinoma 7.6. Chronic sclerosing sialadenitis of sub- mandibular gland (Kuttner tumor) 2.4. Polymorphous low grade 7.7. Cystic lymphoid hyperplasia in AIDS Adenocarcinoma (PLGA) 2.5. Epithelial-myoepithelial carcinoma 2.6. Basal cell adenocarcinoma 2.7. Sebaceous carcinoma 2.8. Papillary cystadenocarcinoma 2.9. Mucinous adenocarcinoma 2.10. Oncocytic carcinoma 2.11. Salivary duct carcinoma 2.12. Adenocarcinoma, NOS 1 Salivary Gland Pathology While the clinical presentation of a salivary gland tumor (SGT) is usually an asymptomatic mass that may occasionally be ulcerated or cause pain, the histologic presentation is far more complex. -
Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation
International Journal of Molecular Sciences Review Current Diagnosis and Treatment Options for Cutaneous Adnexal Neoplasms with Apocrine and Eccrine Differentiation Iga Płachta 1,2,† , Marcin Kleibert 1,2,† , Anna M. Czarnecka 1,* , Mateusz Spałek 1 , Anna Szumera-Cie´ckiewicz 3,4 and Piotr Rutkowski 1 1 Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland; [email protected] (I.P.); [email protected] (M.K.); [email protected] (M.S.); [email protected] (P.R.) 2 Faculty of Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland 3 Department of Pathology and Laboratory Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland; [email protected] 4 Department of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, 00-791 Warsaw, Poland * Correspondence: [email protected] or [email protected] † Equally contributed to the work. Abstract: Adnexal tumors of the skin are a rare group of benign and malignant neoplasms that exhibit morphological differentiation toward one or more of the adnexal epithelium types present in normal skin. Tumors deriving from apocrine or eccrine glands are highly heterogeneous and represent various histological entities. Macroscopic and dermatoscopic features of these tumors are unspecific; therefore, a specialized pathological examination is required to correctly diagnose patients. Limited Citation: Płachta, I.; Kleibert, M.; treatment guidelines of adnexal tumor cases are available; thus, therapy is still challenging. Patients Czarnecka, A.M.; Spałek, M.; should be referred to high-volume skin cancer centers to receive an appropriate multidisciplinary Szumera-Cie´ckiewicz,A.; Rutkowski, treatment, affecting their outcome. -
Conversion of Morphology of ICD-O-2 to ICD-O-3
NATIONAL INSTITUTES OF HEALTH National Cancer Institute to Neoplasms CONVERSION of NEOPLASMS BY TOPOGRAPHY AND MORPHOLOGY from the INTERNATIONAL CLASSIFICATION OF DISEASES FOR ONCOLOGY, SECOND EDITION to INTERNATIONAL CLASSIFICATION OF DISEASES FOR ONCOLOGY, THIRD EDITION Edited by: Constance Percy, April Fritz and Lynn Ries Cancer Statistics Branch, Division of Cancer Control and Population Sciences Surveillance, Epidemiology and End Results Program National Cancer Institute Effective for cases diagnosed on or after January 1, 2001 TABLE OF CONTENTS Introduction .......................................... 1 Morphology Table ..................................... 7 INTRODUCTION The International Classification of Diseases for Oncology, Third Edition1 (ICD-O-3) was published by the World Health Organization (WHO) in 2000 and is to be used for coding neoplasms diagnosed on or after January 1, 2001 in the United States. This is a complete revision of the Second Edition of the International Classification of Diseases for Oncology2 (ICD-O-2), which was used between 1992 and 2000. The topography section is based on the Neoplasm chapter of the current revision of the International Classification of Diseases (ICD), Tenth Revision, just as the ICD-O-2 topography was. There is no change in this Topography section. The morphology section of ICD-O-3 has been updated to include contemporary terminology. For example, the non-Hodgkin lymphoma section is now based on the World Health Organization Classification of Hematopoietic Neoplasms3. In the process of revising the morphology section, a Field Trial version was published and tested in both the United States and Europe. Epidemiologists, statisticians, and oncologists, as well as cancer registrars, are interested in studying trends in both incidence and mortality. -
2014 Slide Library Case Summary Questions & Answers With
2014 Slide Library Case Summary Questions & Answers with Discussions 51st Annual Meeting November 6-9, 2014 Chicago Hilton & Towers Chicago, Illinois The American Society of Dermatopathology ARTHUR K. BALIN, MD, PhD, FASDP FCAP, FASCP, FACP, FAAD, FACMMSCO, FASDS, FAACS, FASLMS, FRSM, AGSF, FGSA, FACN, FAAA, FNACB, FFRBM, FMMS, FPCP ASDP REFERENCE SLIDE LIBRARY November 2014 Dear Fellows of the American Society of Dermatopathology, The American Society of Dermatopathology would like to invite you to submit slides to the Reference Slide Library. At this time there are over 9300 slides in the library. The collection grew 2% over the past year. This collection continues to grow from member’s generous contributions over the years. The slides are appreciated and are here for you to view at the Sally Balin Medical Center. Below are the directions for submission. Submission requirements for the American Society of Dermatopathology Reference Slide Library: 1. One H & E slide for each case (if available) 2. Site of biopsy 3. Pathologic diagnosis Not required, but additional information to include: 1. Microscopic description of the slide illustrating the salient diagnostic points 2. Clinical history and pertinent laboratory data, if known 3. Specific stain, if helpful 4. Clinical photograph 5. Additional note, reference or comment of teaching value Teaching sets or collections of conditions are especially useful. In addition, infrequently seen conditions are continually desired. Even a single case is helpful. Usually, the written submission requirement can be fulfilled by enclosing a copy of the pathology report prepared for diagnosis of the submitted case. As a guideline, please contribute conditions seen with a frequency of less than 1 in 100 specimens. -
Cytological Diagnosis of Cylindroma Scalp- a Rare Case Report Dr
Saudi Journal of Pathology and Microbiology Abbreviated Key Title: Saudi J Pathol Microbiol ISSN 2518-3362 (Print) |ISSN 2518-3370 (Online) Scholars Middle East Publishers, Dubai, United Arab Emirates Journal homepage: https://saudijournals.com/sjpm Case Report Cytological Diagnosis of Cylindroma Scalp- A Rare Case Report 1*, 2 3 4 Dr. Sabina Khan Dr. Sayika Hameed , Dr. Nehal Ahmad MD , Dr. Rubeena Mohroo MD , Dr. Mohd. Jaseem Hassan 5 6 MD , Prof. Sujata Jetley MD 1,5Associate Professor, Department of Pathology, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard New Delhi 110062, India 22nd year post graduate, Pathology, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard New Delhi 110062, India 3Assistant Professor Pathology, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard New Delhi 110062, India 4Demonstrator Pathology, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard New Delhi 110062, India 6Professor and Head Pathology, Hamdard Institute of Medical Sciences and Research, Jamia Hamdard New Delhi 110062, India DOI: 10.36348/sjpm.2020.v05i05.009 | Received: 07.05.2020 | Accepted: 14.05.2020 | Published: 21.05.2020 *Corresponding author: Dr. Sabina Khan Abstract Cylindromas are rare slow growing benign skin appendageal tumors with eccrine and apocrine differentiation. Multiple cylindromas are commonly genetically inherited and also known as “turban tumor.” Here, we have discussed a case of scalp swelling in a male patient having lung cancer, which was clinically suspicious of metastasis. However, cytology revealed many clusters of small round to oval basaloid cells surrounded and attached with magenta coloured acellular hyaline material. The cells had very scanty cytoplasm and dark, round to oval hyperchromatic nuclei without any nuclear membrane irregularity. -
The Convergent Roles of the Nuclear Factor I Transcription Factors in Development and Cancer
The convergent roles of the nuclear factor I transcription factors in development and cancer Kok-Siong Chen1, Jonathan W.C. Lim1, Linda J. Richards1,2*, Jens Bunt1* 1 Queensland Brain Institute, The University of Queensland, Brisbane, Australia 4072 2 The School of Biomedical Sciences, The University of Queensland, Brisbane, Australia 4072 * Corresponding authors: Jens Bunt: [email protected] and Linda J Richards: [email protected] 1 Highlights • NFI transcription factors play important roles in normal development and are associated with cancer in multiple organ systems. • NFI transcription factors are implicated in tumours that arise from cells that normally express the concordant transcription factor during development. • The role of NFI transcription factors in regulating the balance between cell proliferation and differentiation during development may be disrupted in cancer. • NFI transcription factors are context-dependent in various cancer types and can play either oncogenic or tumour-suppressive roles. 2 Abstract The nuclear factor I (NFI) transcription factors play important roles during normal development and have been associated with developmental abnormalities in humans. All four family members, NFIA, NFIB, NFIC and NFIX, have a homologous DNA binding domain and function by regulating cell proliferation and differentiation via the transcriptional control of their target genes. More recently, NFI genes have also been implicated in cancer based on genomic analyses and studies of animal models in a variety of tumours across multiple organ systems. However, the association between their functions in development and in cancer is not well described. In this review, we summarise the evidence suggesting a converging role for the NFI genes in development and cancer. -
Syndrome of the Month Dermal Eccrine Cylindromatosis
Med Genet 1994;31:321-324 321 Syndrome of the month J Med Genet: first published as 10.1136/jmg.31.4.321 on 1 April 1994. Downloaded from Dermal eccrine cylindromatosis I D C van Balkom, R C M Hennekam In 1842 Ancell' first described an entity char- acterised by a striking clinical picture of multi- ple disfiguring tumours located on the face and scalp, which rapidly recurred after excision, had a distinctive histology, and showed fami- lial occurrence. Differences of opinion as to the pathogenesis of the lesion and especially the various names used (including epithelioma adenoides cysticum, multiple benign cystic epithelioma, multiple trichoepithelioma, tur- ban tumour, tomato tumour, Spiegler's cylin- droma, or dermal cylindroma) have led to considerable confusion. An extensive study by Figure 1 Small dermal eccrine cylindromata around Cotton and Braye2 strongly supported earlier the nose and on the nasal bridge in an adult male. reports3 4 of evidence for an eccrine intrader- mal origin. Therefore, we have adopted the term "dermal eccrine cylindroma" to include dermal eccrine cylindroma develop chiefly in the origin of the tumours. A rare subtype of the frontal and tempoparietal regions of the dermal eccrine cylindroma is called turban scalp2 (fig 2). The larger dermal eccrine cylin- tumour, a highly descriptive label for the clas- dromata are hairless, firm, and nodular, resis- sical total involvement of the scalp with tent to the touch and mobile on the underlying tumours covering the head and causing gross galea, while being firmly attached to the skin. disfigurement.51'0 They may occur in such numbers as to cover the scalp more or less completely3 6 7 10 11 which http://jmg.bmj.com/ are called turban tumours. -
Dr Sarma's Dermpath: Quick Diagnosis (100 Cases)
Dr Sarma’s Dermpath: Quick diagnosis (100 cases) 1. Superficial BCC 2. Invasive SCC 3. Neurofibroma 4. Granular cell tumor 5. Clear cell acanthoma 6. Chondroid syringoma (Cutaneous mixed tumor) 7. Scabies 8. Molluscum contagiosum 9. Herpes simplex 10. Hemangioma 11. Basosquamous cell carcinoma 12. Dermal cylindroma 13. Psoriasis vulgaris 14. Proliferating pilar tumor 15. Pilar cyst 16. Nodular BCC 17. Nevus lipomatosus superficialis 18. Glomangioma 19. Chromomycosis 20. Blue nevus 21. Pemphigus vulgaris 22. Halo nevus 23. Acute febrile neutrophilic dermatosis (Sweet’s syndrome) 24. Angiolipoma 25. Angioleiomyoma 26. Bullous pemphigoid 27. Trichoepithelioma 28. Acquired digital fibrokeratoma 29. Basal cell carcinoma, fibroepithelioma of Pinkus type (Fibroepithelioma of Pinkus) 30. Sclerosing basal cell carcinoma (Morpheaform basal cell carcinoma) 31. Squamous cell carcinoma in situ 32. Basal cell carcinoma, pilar type 33. Apocrine hidrocystoma 34. Cystic spiradenoma 35. Acral fibrokeratoma 36. Blastomycosis 37. Dermatophytosis (Tinea) 38. Tick-bite dermatitis 39. Epidermal nevus 40. Acrochordon (Fibroepitelial polyp, Squamous papilloma, Skin tag) 41. Squamous cell carcinoma, in situ and invasive 42. Desmoplastic melanoma 43. Keratoacanthoma 44. Sebaceous hyperplasia 45. Majocchi’s granuloma 46. Schwannoma 47. Lichen sclerosus et atrophicus 48. Lichen planus 49. Lentigo simplex 50. Alopecia areata 51. Acantholytic squamous cell carcinoma 52. Melanoma in situ 53. Steatocystoma 54. Sebaceous adenoma 55. Pyogenic granuloma 56. Darier disease 57. Balanitis circumscripta plasmacellularis 58. Acrochordon 59. Dermatofibroma 60. Xanthogranuloma 61. Basal cell carcinoma, infiltrative type 62. Cutaneous lupus erythematosus 63. Angiokeratoma 64. Piloleiomyoma 65. Sarcoidosis 66. Angioleiomyoma 67. Scrotal leiomyoma (Genital leiomyoma) 68. Lipomatous dermal melanocytic nevus 69. Seborrheic keratosis 70. Cutaneous dermoid cyst 71.